| Literature DB >> 17621752 |
Harirak Wanmuang1, Juvady Leopairut, Chomsri Kositchaiwat, Winai Wananukul, Sukhum Bunyaratvej.
Abstract
Hepatotoxic effect related to Ganoderma lucidum (Lingzhi) mushroom powder was first described in a patient from Hong Kong in 2004. In 2005, the authors experienced a case of fatal fulminant hepatitis associated with such a preparation. Both patients had taken other therapeutic agents and traditionally boiled Lingzhi without any toxic effect. After switching to taking Lingzhi in powder form for 1-2 months, the hepatotoxic episode occurred in both patients. The toxic role of Lingzhi powder needs close monitoring in the future, especially in combination with other drugs.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17621752
Source DB: PubMed Journal: J Med Assoc Thai ISSN： 0125-2208